AXGN Axogen, Inc.
Nasdaq · SEC CIK 805928 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $19.88M 31 sales by 12 insiders
- Filings on record
- 236 since 2021-07-21, latest 2026-09-04 16:08
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Began Marc A | EVP, GC | — | $3.88M |
| Burke William P. Mr. | Dir | — | $2.82M |
| Weiler Kathy Johnson | Dir | — | $2.74M |
| DALE MICHAEL D | CEO | — | $2.67M |
| Wendell Amy McBride | Dir | — | $2.00M |
| JOHNSON JOHN | Dir | — | $1.87M |
| TYNDALL JOSEPH A. | Dir | — | $951.8K |
| Hartley Lindsey Marie | CFO | — | $942.2K |
| DeVinney Erick Wayne | Chief Innovation Off | — | $780.6K |
| THOMAS PAUL | Dir | — | $633.6K |
Transactions 312
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-26 | 2025-02-25 | AXGN | Kemp Jens | CMO | F - Tax | $16.49 | -814 | 1,686 | -33% | -$13.4K | |
| 2025-01-06 | 2025-01-06 | AXGN | Naor Nir | CFO | F - Tax | $15.22 | -39.1K | 260.9K | -13% | -$595.6K | |
| 2024-09-17 | 2024-09-16 | AXGN | THOMAS PAUL | Dir | A - Grant | — | +2,875 | 34.9K | +9% | — | |
| 2024-09-13 | 2024-09-13 | AXGN | DeVinney Erick Wayne | Chief Innovation Off | A - Grant | $0.00 | +2,500 | 180.0K | +1% | $0 | |
| D | 2024-09-04 | 2024-09-01 | AXGN | TYNDALL JOSEPH A. | Dir | M - OptEx | $0.00 | +11.9K | 22.6K | +112% | $0 |
| D | 2024-09-04 | 2024-09-01 | AXGN | THOMAS PAUL | Dir | M - OptEx | $0.00 | +11.9K | 32.1K | +59% | $0 |
| D | 2024-09-04 | 2024-09-01 | AXGN | Levine Alan M | Dir | M - OptEx | $0.00 | +11.9K | 40.8K | +41% | $0 |
| D | 2024-09-04 | 2024-09-01 | AXGN | Burke William P. Mr. | Dir | M - OptEx | $0.00 | +11.9K | 28.6K | +71% | $0 |
| D | 2024-09-04 | 2024-09-01 | AXGN | Wendell Amy McBride | Dir | M - OptEx | $0.00 | +11.9K | 102.9K | +13% | $0 |
| D | 2024-09-04 | 2024-09-01 | AXGN | NEELS GUIDO J | Dir | M - OptEx | $0.00 | +11.9K | 90.8K | +15% | $0 |
| D | 2024-09-04 | 2024-09-01 | AXGN | JOHNSON JOHN | Dir | M - OptEx | $0.00 | +11.9K | 29.0K | +70% | $0 |
| D | 2024-06-10 | 2024-06-06 | AXGN | NEELS GUIDO J | Dir | A - Grant | — | +10.7K | 78.9K | +16% | — |
| D | 2024-06-10 | 2024-06-06 | AXGN | Wendell Amy McBride | Dir | A - Grant | — | +10.7K | 91.0K | +13% | — |
| D | 2024-06-10 | 2024-06-06 | AXGN | Weiler Kathy Johnson | Dir | A - Grant | — | +10.7K | 10.7K | New | — |
| D | 2024-06-10 | 2024-06-06 | AXGN | Burke William P. Mr. | Dir | A - Grant | — | +10.7K | 16.7K | +178% | — |
| D | 2024-06-10 | 2024-06-06 | AXGN | JOHNSON JOHN | Dir | A - Grant | — | +10.7K | 17.1K | +165% | — |
| D | 2024-06-10 | 2024-06-06 | AXGN | TYNDALL JOSEPH A. | Dir | A - Grant | — | +10.7K | 10.7K | New | — |
| D | 2024-06-10 | 2024-06-06 | AXGN | Levine Alan M | Dir | A - Grant | — | +10.7K | 28.9K | +58% | — |
| D | 2024-06-10 | 2024-06-06 | AXGN | THOMAS PAUL | Dir | A - Grant | — | +10.7K | 20.1K | +112% | — |
| D | 2024-06-06 | 2024-06-04 | AXGN | Freitag Gregory Gene | Dir | M - OptEx | $0.00 | +11.9K | 283.5K | +4% | $0 |
| DM | 2024-03-25 | 2024-03-21 | AXGN | DeVinney Erick Wayne | Chief Innovation Off | S - Sale+OE | $7.68 | -4,578 | 167.9K | -3% | -$35.2K |
| DM | 2024-03-25 | 2024-03-16 | AXGN | DeVinney Erick Wayne | Chief Innovation Off | M - OptEx | $0.00 | +18.7K | 166.4K | +13% | $0 |
| DM | 2024-03-25 | 2024-03-16 | AXGN | Zaderej Karen L. | CEO, Dir | M - OptEx | $0.00 | +110.3K | 1.16M | +11% | $0 |
| DM | 2024-03-25 | 2024-03-21 | AXGN | Zaderej Karen L. | CEO, Dir | S - Sale+OE | $7.68 | -39.3K | 1.14M | -3% | -$301.7K |
| DM | 2024-03-25 | 2024-03-21 | AXGN | Scopelianos Angelo | Chief R, D Off | S - Sale+OE | $7.68 | -6,881 | 53.0K | -11% | -$52.8K |
| DM | 2024-03-25 | 2024-03-16+ | AXGN | Scopelianos Angelo | Chief R, D Off | M - OptEx | $0.00 | +27.9K | 58.6K | +91% | $0 |
| DM | 2024-03-25 | 2024-03-21 | AXGN | Donovan Michael Patrick | VP Ops | S - Sale+OE | $7.68 | -6,033 | 54.2K | -10% | -$46.3K |
| DM | 2024-03-25 | 2024-03-16 | AXGN | Donovan Michael Patrick | VP Ops | M - OptEx | $0.00 | +24.6K | 58.8K | +72% | $0 |
| 2024-03-08 | 2024-03-07 | AXGN | Freitag Gregory Gene | Dir | S - Sale | $9.00 | -25.0K | 271.6K | -8% | -$225.0K | |
| 2024-03-08 | 2024-03-07 | AXGN | Donovan Michael Patrick | VP Ops | S - Sale | $8.81 | -36.3K | 35.7K | -50% | -$319.9K | |
| 2024-03-05 | 2024-03-01 | AXGN | DeVinney Erick Wayne | Chief Innovation Off | A - Grant | — | +50.0K | 163.4K | +44% | — | |
| 2024-01-04 | 2024-01-01 | AXGN | Naor Nir | CFO | A - Grant | — | +300.0K | 300.0K | New | — | |
| M | 2023-12-13 | 2023-12-11 | AXGN | MARIANI PETER J | EVP, CFO | S - Sale | $7.50 | -12.5K | 71.6K | -15% | -$93.8K |
| 2023-10-13 | 2023-07-18 | AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | A - Grant | $0.00 | +1,579 | 114.2K | +1% | $0 | |
| 2023-10-13 | 2023-10-13 | AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | D - Sale to Iss | $4.04 | -864 | 113.4K | -0.8% | -$3,491 | |
| 2023-10-13 | 2023-10-13 | AXGN | Scopelianos Angelo | Chief R, D Off | D - Sale to Iss | $4.04 | -1,403 | 37.0K | -4% | -$5,668 | |
| 2023-10-13 | 2023-07-18 | AXGN | Scopelianos Angelo | Chief R, D Off | A - Grant | $0.00 | +2,571 | 38.4K | +7% | $0 | |
| 2023-10-13 | 2023-10-13 | AXGN | MARTINEZ MARIA D. | CHRO | D - Sale to Iss | $4.04 | -1,403 | 30.5K | -4% | -$5,668 | |
| 2023-10-13 | 2023-07-18 | AXGN | MARTINEZ MARIA D. | CHRO | A - Grant | $0.00 | +2,571 | 31.9K | +9% | $0 | |
| 2023-10-13 | 2023-10-13 | AXGN | Donovan Michael Patrick | VP Ops | D - Sale to Iss | $4.04 | -1,403 | 72.0K | -2% | -$5,668 | |
| 2023-10-13 | 2023-07-18 | AXGN | Donovan Michael Patrick | VP Ops | A - Grant | $0.00 | +2,571 | 73.4K | +4% | $0 | |
| 2023-10-13 | 2023-10-13 | AXGN | MARIANI PETER J | EVP, CFO | D - Sale to Iss | $4.04 | -3,263 | 76.1K | -4% | -$13.2K | |
| 2023-10-13 | 2023-07-18 | AXGN | MARIANI PETER J | EVP, CFO | A - Grant | $0.00 | +3,709 | 79.4K | +5% | $0 | |
| 2023-10-13 | 2023-07-18 | AXGN | Zaderej Karen L. | CEO, Dir | A - Grant | $0.00 | +22.1K | 1.07M | +2% | $0 | |
| 2023-09-08 | 2023-09-06 | AXGN | Wendell Amy McBride | Dir | P - Purchase | $6.22 | +10.0K | 80.3K | +14% | +$62.2K | |
| I | 2023-08-25 | 2023-08-23 | AXGN | Burke William P. Mr. | Dir | P - Purchase | $6.56 | +10.0K | 10.0K | New | +$65.6K |
| 2023-08-25 | 2023-08-24 | AXGN | Burke William P. Mr. | Dir | A - Grant | $6.31 | +6,000 | 6,000 | New | +$37.9K | |
| 2023-08-18 | 2023-08-16 | AXGN | NEELS GUIDO J | Dir | P - Purchase | $6.11 | +10.0K | 68.3K | +17% | +$61.1K | |
| D | 2023-06-05 | 2023-06-01 | AXGN | NEELS GUIDO J | Dir | M - OptEx | $0.00 | +6,459 | 58.3K | +12% | $0 |
| D | 2023-06-05 | 2023-06-01 | AXGN | THOMAS PAUL | Dir | M - OptEx | $0.00 | +6,459 | 9,495 | +213% | $0 |
| DM | 2023-06-05 | 2023-06-01 | AXGN | Freitag Gregory Gene | Dir | S - Sale+OE | $8.71 | -42.0K | 290.1K | -13% | -$365.8K |
| D | 2023-06-05 | 2023-06-01 | AXGN | Freitag Gregory Gene | Dir | M - OptEx | $0.00 | +6,459 | 296.6K | +2% | $0 |
| D | 2023-06-05 | 2023-06-01 | AXGN | Wendell Amy McBride | Dir | M - OptEx | $0.00 | +6,459 | 70.3K | +10% | $0 |
| D | 2023-06-05 | 2023-06-01 | AXGN | JOHNSON JOHN | Dir | M - OptEx | $0.00 | +6,459 | 6,459 | New | $0 |
| D | 2023-06-05 | 2023-06-01 | AXGN | Levine Alan M | Dir | M - OptEx | $0.00 | +6,459 | 18.3K | +55% | $0 |
| M | 2023-05-24 | 2023-05-23 | AXGN | Freitag Gregory Gene | Dir | S - Sale | $9.23 | -7,468 | 332.1K | -2% | -$68.9K |
| DM | 2023-05-16 | 2023-05-12 | AXGN | Wendell Amy McBride | Dir | M - OptEx | $9.22 | +28.8K | 60.1K | +92% | +$265.1K |
| DM | 2023-03-20 | 2023-03-16 | AXGN | Scopelianos Angelo | Chief R, D Off | F - Tax | $8.27 | -3,907 | 36.7K | -10% | -$32.3K |
| DM | 2023-03-20 | 2023-03-16 | AXGN | Scopelianos Angelo | Chief R, D Off | M - OptEx | $0.00 | +13.8K | 39.7K | +53% | $0 |
| DM | 2023-03-20 | 2023-03-16 | AXGN | Zaderej Karen L. | CEO, Dir | M - OptEx | $0.00 | +38.0K | 1.04M | +4% | $0 |
| DM | 2023-03-20 | 2023-03-16 | AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | F - Tax | $8.27 | -2,769 | 112.7K | -2% | -$22.9K |
| DM | 2023-03-20 | 2023-03-16 | AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | M - OptEx | $0.00 | +8,900 | 113.6K | +9% | $0 |
| DM | 2023-03-20 | 2023-03-16 | AXGN | Ottinger Bradley | GC, CCO | F - Tax | $8.27 | -2,634 | 22.9K | -10% | -$21.8K |
| DM | 2023-03-20 | 2023-03-16 | AXGN | Ottinger Bradley | GC, CCO | M - OptEx | $0.00 | +8,463 | 23.7K | +56% | $0 |
| DM | 2023-03-20 | 2023-03-16 | AXGN | MARIANI PETER J | EVP, CFO | F - Tax | $8.27 | -7,038 | 75.7K | -9% | -$58.2K |
| DM | 2023-03-20 | 2023-03-16 | AXGN | MARIANI PETER J | EVP, CFO | M - OptEx | $0.00 | +20.8K | 67.4K | +44% | $0 |
| DM | 2023-03-20 | 2023-03-16 | AXGN | MARTINEZ MARIA D. | CHRO | F - Tax | $8.27 | -4,270 | 21.1K | -17% | -$35.3K |
| DM | 2023-03-20 | 2023-03-16 | AXGN | MARTINEZ MARIA D. | CHRO | M - OptEx | $0.00 | +14.5K | 26.4K | +123% | $0 |
| DM | 2023-03-20 | 2023-03-16 | AXGN | Donovan Michael Patrick | VP Ops | M - OptEx | $0.00 | +8,900 | 67.7K | +15% | $0 |
| DM | 2023-03-20 | 2023-03-16 | AXGN | Donovan Michael Patrick | VP Ops | F - Tax | $8.27 | -2,769 | 70.8K | -4% | -$22.9K |
| DM | 2023-02-01 | 2023-01-30+ | AXGN | MARIANI PETER J | EVP, CFO | M - OptEx | $5.04 | +62.8K | 63.0K | +27,431% | +$316.6K |
| DM | 2023-02-01 | 2023-01-30+ | AXGN | MARIANI PETER J | EVP, CFO | S - Sale+OE | $9.53 | -43.0K | 55.6K | -44% | -$409.7K |
| DM | 2023-01-27 | 2023-01-25+ | AXGN | MARIANI PETER J | EVP, CFO | S - Sale+OE | $10.10 | -62.8K | 42.1K | -60% | -$634.3K |
| DM | 2023-01-27 | 2023-01-25+ | AXGN | MARIANI PETER J | EVP, CFO | M - OptEx | $5.04 | +62.8K | 63.0K | +27,431% | +$316.6K |
| D | 2022-12-29 | 2022-12-27 | AXGN | Billet Isabelle | Chief Strategy, BD Off | F - Tax | $9.44 | -327 | 25.1K | -1% | -$3,087 |
| D | 2022-12-29 | 2022-12-27 | AXGN | Billet Isabelle | Chief Strategy, BD Off | M - OptEx | $0.00 | +1,150 | 25.4K | +5% | $0 |
| D | 2022-12-29 | 2022-12-27 | AXGN | Donovan Michael Patrick | VP Ops | F - Tax | $9.44 | -286 | 64.7K | -0.4% | -$2,700 |
| D | 2022-12-29 | 2022-12-27 | AXGN | Donovan Michael Patrick | VP Ops | M - OptEx | $0.00 | +1,150 | 65.0K | +2% | $0 |
| D | 2022-12-29 | 2022-12-27 | AXGN | Scopelianos Angelo | Chief R, D Off | M - OptEx | $0.00 | +1,150 | 26.2K | +5% | $0 |
| D | 2022-12-29 | 2022-12-27 | AXGN | Scopelianos Angelo | Chief R, D Off | F - Tax | $9.44 | -286 | 26.0K | -1% | -$2,700 |
| D | 2022-12-29 | 2022-12-27 | AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | F - Tax | $9.44 | -187 | 106.5K | -0.2% | -$1,765 |
| D | 2022-12-29 | 2022-12-27 | AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | M - OptEx | $0.00 | +750 | 106.7K | +0.7% | $0 |
| D | 2022-12-29 | 2022-12-27 | AXGN | MARIANI PETER J | EVP, CFO | F - Tax | $9.44 | -649 | 42.1K | -2% | -$6,127 |
| D | 2022-12-29 | 2022-12-27 | AXGN | MARIANI PETER J | EVP, CFO | M - OptEx | $0.00 | +2,625 | 42.8K | +7% | $0 |
| D | 2022-12-29 | 2022-12-27 | AXGN | MARTINEZ MARIA D. | CHRO | F - Tax | $9.44 | -286 | 19.1K | -1% | -$2,700 |
| D | 2022-12-29 | 2022-12-27 | AXGN | MARTINEZ MARIA D. | CHRO | M - OptEx | $0.00 | +1,150 | 19.3K | +6% | $0 |
| D | 2022-12-29 | 2022-12-27 | AXGN | Zaderej Karen L. | CEO, Dir | M - OptEx | $0.00 | +4,400 | 1.01M | +0.4% | $0 |
| D | 2022-12-28 | 2022-12-27 | AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | M - OptEx | $5.09 | +20.0K | 116.8K | +21% | +$101.8K |
| D | 2022-12-28 | 2022-12-27 | AXGN | DeVinney Erick Wayne | VP Peripheral Nerve Science | F - Tax | $9.44 | -10.8K | 106.0K | -9% | -$101.8K |
| D | 2022-12-16 | 2022-12-15 | AXGN | Zaderej Karen L. | CEO, Dir | M - OptEx | $5.09 | +26.7K | 1.01M | +3% | +$136.1K |
| D | 2022-12-16 | 2022-12-14 | AXGN | MARIANI PETER J | EVP, CFO | M - OptEx | $5.04 | +19.4K | 49.1K | +65% | +$97.6K |
| D | 2022-12-16 | 2022-12-14 | AXGN | MARIANI PETER J | EVP, CFO | F - Tax | $10.93 | -8,930 | 40.1K | -18% | -$97.6K |
| 2022-11-18 | 2022-11-16 | AXGN | MARIANI PETER J | EVP, CFO | S - Sale | $11.88 | -10.6K | 29.7K | -26% | -$126.5K | |
| 2022-11-16 | 2022-11-14 | AXGN | Freitag Gregory Gene | Dir | S - Sale | $12.74 | -13.0K | 339.6K | -4% | -$165.6K | |
| 2022-11-10 | 2022-11-08 | AXGN | Freitag Gregory Gene | Dir | S - Sale | $12.50 | -13.0K | 352.6K | -4% | -$162.5K | |
| 2022-08-11 | 2022-08-10 | AXGN | Freitag Gregory Gene | Dir | S - Sale | $9.70 | -8,886 | 365.6K | -2% | -$86.2K | |
| M | 2022-08-08 | 2022-08-04+ | AXGN | Freitag Gregory Gene | Dir | S - Sale | $10.54 | -37.0K | 387.5K | -9% | -$390.6K |
| D | 2022-07-26 | 2022-07-25 | AXGN | Freitag Gregory Gene | Dir | F - Tax | $9.26 | -30.3K | 411.5K | -7% | -$280.5K |
| D | 2022-07-26 | 2022-07-25 | AXGN | Freitag Gregory Gene | Dir | M - OptEx | $3.38 | +83.0K | 441.8K | +23% | +$280.5K |
| 2022-07-20 | 2022-07-19 | AXGN | Scopelianos Angelo | Chief R, D Off | D - Sale to Iss | $8.40 | -657 | 25.1K | -3% | -$5,519 |
Purchase Sale Sale after option exercise All abbreviations